ADORA2A and Parkinson disease: Neuroinflammation accompanying the lesion in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) rodent model of PD can also be reverted by intraperitoneal administration of A2AR antagonists [13].